137 related articles for article (PubMed ID: 33480300)
21. Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.
Zaki A; Fawzy A; Akel SY; Gamal H; Elshimy RAA
Asian Pac J Cancer Prev; 2022 Feb; 23(2):723-730. PubMed ID: 35225486
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of microRNA-101-3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9.
Sun H; Guo F; Xu L
J Cell Biochem; 2020 Oct; 121(10):4310-4320. PubMed ID: 31904179
[TBL] [Abstract][Full Text] [Related]
23. HDAC9 Silencing Exerts Neuroprotection Against Ischemic Brain Injury
Zhong L; Yan J; Li H; Meng L
Front Cell Neurosci; 2020; 14():544285. PubMed ID: 33584204
[TBL] [Abstract][Full Text] [Related]
24. MiR-376a and histone deacetylation 9 form a regulatory circuitry in hepatocellular carcinoma.
Zheng Y; Chen H; Yin M; Ye X; Chen G; Zhou X; Yin L; Zhang C; Ding B
Cell Physiol Biochem; 2015; 35(2):729-39. PubMed ID: 25613642
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
26. Astragaloside IV Protects Rat Cardiomyocytes from Hypoxia-Induced Injury by Down-Regulation of miR-23a and miR-92a.
Gong L; Chang H; Zhang J; Guo G; Shi J; Xu H
Cell Physiol Biochem; 2018; 49(6):2240-2253. PubMed ID: 30257251
[TBL] [Abstract][Full Text] [Related]
27. SRPK1 gene silencing promotes vascular smooth muscle cell proliferation and vascular remodeling via inhibition of the PI3K/Akt signaling pathway in a rat model of intracranial aneurysms.
Li XG; Wang YB
CNS Neurosci Ther; 2019 Feb; 25(2):233-244. PubMed ID: 30101479
[TBL] [Abstract][Full Text] [Related]
28. miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11.
Niu H; Wang K; Zhang A; Yang S; Song Z; Wang W; Qian C; Li X; Zhu Y; Wang Y
Oncol Rep; 2012 Nov; 28(5):1771-7. PubMed ID: 22895567
[TBL] [Abstract][Full Text] [Related]
29. microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.
Sing T; Jinnin M; Yamane K; Honda N; Makino K; Kajihara I; Makino T; Sakai K; Masuguchi S; Fukushima S; Ihn H
Rheumatology (Oxford); 2012 Sep; 51(9):1550-6. PubMed ID: 22661558
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA CBR3 antisense RNA 1 promotes the aggressive phenotypes of non‑small‑cell lung cancer by sponging microRNA‑509‑3p and competitively upregulating HDAC9 expression.
Guan Y; Yang J; Liu X; Chu L
Oncol Rep; 2020 Oct; 44(4):1403-1414. PubMed ID: 32945466
[TBL] [Abstract][Full Text] [Related]
31. Novel Interaction of Class IIb Histone Deacetylase 6 (HDAC6) with Class IIa HDAC9 Controls Gonadotropin Releasing Hormone (GnRH) Neuronal Cell Survival and Movement.
Salian-Mehta S; Xu M; McKinsey TA; Tobet S; Wierman ME
J Biol Chem; 2015 May; 290(22):14045-56. PubMed ID: 25873389
[TBL] [Abstract][Full Text] [Related]
32. Long Non-coding RNA MALAT1/microRNA-143/VEGFA Signal Axis Modulates Vascular Endothelial Injury-Induced Intracranial Aneurysm.
Gao G; Zhang Y; Yu J; Chen Y; Gu D; Niu C; Fu X; Wei J
Nanoscale Res Lett; 2020 Jun; 15(1):139. PubMed ID: 32602008
[TBL] [Abstract][Full Text] [Related]
33. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability.
Asare Y; Campbell-James TA; Bokov Y; Yu LL; Prestel M; El Bounkari O; Roth S; Megens RTA; Straub T; Thomas K; Yan G; Schneider M; Ziesch N; Tiedt S; Silvestre-Roig C; Braster Q; Huang Y; Schneider M; Malik R; Haffner C; Liesz A; Soehnlein O; Bernhagen J; Dichgans M
Circ Res; 2020 Aug; 127(6):811-823. PubMed ID: 32546048
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-92a Promotes Cell Proliferation in Cervical Cancer via Inhibiting p21 Expression and Promoting Cell Cycle Progression.
Su Z; Yang H; Zhao M; Wang Y; Deng G; Chen R
Oncol Res; 2017 Jan; 25(1):137-145. PubMed ID: 28081742
[TBL] [Abstract][Full Text] [Related]
35. Synergistic Expression of Histone Deacetylase 9 and Matrix Metalloproteinase 12 in M4 Macrophages in Advanced Carotid Plaques.
Oksala NKJ; Seppälä I; Rahikainen R; Mäkelä KM; Raitoharju E; Illig T; Klopp N; Kholova I; Laaksonen R; Karhunen PJ; Hytönen VP; Lehtimäki T
Eur J Vasc Endovasc Surg; 2017 May; 53(5):632-640. PubMed ID: 28343758
[TBL] [Abstract][Full Text] [Related]
36. miR-27a promotion resulting from silencing of HDAC3 facilitates the recovery of spinal cord injury by inhibiting PAK6 expression in rats.
Zhou Q; Feng X; Ye F; Lei F; Jia X; Feng D
Life Sci; 2020 Nov; 260():118098. PubMed ID: 32679145
[TBL] [Abstract][Full Text] [Related]
37. STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells.
Lin HY; Chiang CH; Hung WC
Br J Cancer; 2013 Aug; 109(3):731-8. PubMed ID: 23820254
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of HDAC9 promotes oral squamous cell carcinoma growth, regulates cell cycle progression, and inhibits apoptosis.
Rastogi B; Raut SK; Panda NK; Rattan V; Radotra BD; Khullar M
Mol Cell Biochem; 2016 Apr; 415(1-2):183-96. PubMed ID: 26992905
[TBL] [Abstract][Full Text] [Related]
39. HDAC9 exacerbates endothelial injury in cerebral ischaemia/reperfusion injury.
Shi W; Wei X; Wang Z; Han H; Fu Y; Liu J; Zhang Y; Guo J; Dong C; Zhou D; Zhou Q; Chen Y; Yi F
J Cell Mol Med; 2016 Jun; 20(6):1139-49. PubMed ID: 26865248
[TBL] [Abstract][Full Text] [Related]
40. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis.
Markus HS; Mäkelä KM; Bevan S; Raitoharju E; Oksala N; Bis JC; O'Donnell C; Hainsworth A; Lehtimäki T
Stroke; 2013 May; 44(5):1220-5. PubMed ID: 23449258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
